跳至主要内容
临床试验/JPRN-UMIN000006861
JPRN-UMIN000006861招募中3 期

Randomized controlled trial to investigate the retention time of intravesical instillation therapy with pirarubicin for non-muscule invasive bladder cancer following transurethral resection of bladder tumor. - Investigation of retention time of intravesical instillation therapy with pirarubicin for non-muscule invasive bladder cancer.Investigation of retention time of intravesical instillation therapy with pirarubicin for non-muscule invasive bladder cancer.

Kumamoto Univeristy0 个研究点目标入组 160 人开始时间: 2011年12月9日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who previously underwent intravesical therapy with BCG. 2. The patients underwent maintenance intravesical therapy of an anticancer agent. 3. Patients with active other malignant disease. 4. Patients with historically or presently disease of upper urinary tract urothelial cell carcinoma. 5. Funcion of all organs are without severe dysfunction. 6. Inappropriate patients for this study judged by the physicians.

研究者

发起方
Kumamoto Univeristy

相似试验